AI combining tissue slides and gene scores flags early lung cancer recurrence risk, but is not yet ready to guide care
Researchers built PATH-ORACLE, a multimodal deep learning biomarker that adds routine histological sections, read by pretrained foundation models, to an existing validated transcriptomic risk score for stage I lung adenocarcinoma.
Immuno-Oncology and Technology
ace

